Skip to content
OpenCapital
Get started

Castle Biosciences CSTL Business Segments — Inventory usage

Similar metrics at other companies

SIT
SITEReportable Segment — Inventory costs, net of supplier incentives and discounts
$558.3M-3.1%
Funko, Inc. logo
FNKOReportable Segment — Product, freight, duties, shipping and other inventoriable costs
$81.91M+0.9%
Recursion Pharmaceuticals, Inc. logo
RXRXReportable Segment — Consumables
$7.15M-86.9%
Rollins logo
ROLReportable Segment — Materials and supplies
$53.22M+9.7%
ARD
ARDTReportable Segment — Supplies
$268.55M+3.7%
Pacific Biosciences of California logo
PACBReportable Segment — Cost of revenue
$24.34M-36.8%

Other financials

Income statement

See full
Revenue$83.7M-4.9%
Gross profit$63.1M-11.8%
Operating income-$18.4M+34.1%
Net income-$14.5M+43.8%
EPS (diluted)-$0.49+45.6%

Balance sheet

See full
Cash & equivalents$63.8M-28.9%
Total debt$36.7M+42.1%
Total equity$461.4M+4.8%
Total assets$547.8M+9.2%

Cash flow

See full
Operating cash flow-$22.1M-267%
CapEx$12.5M+163%
Free cash flow-$34.6M-221%

Valuation

See full
Market cap$694.86M+29.9%
Enterprise value$667.82M+41.8%
P/S2×+0.5×

Profitability

See full
Gross margin77.9%-4.1pp
Operating margin-9.8%-30.8pp
Net margin-3.8%-10.2pp
FCF margin1.3%-10.7pp

Returns & leverage

See full
Return on equity-2.8%-10.6pp
Debt / equity0.1×0.0×
Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept cstl:InventoryUsage.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's business segments — inventory usage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Castle Biosciences's business segments — inventory usage?
Castle Biosciences (CSTL) reported business segments — inventory usage of $6.44M in Q1 2026.
How has Castle Biosciences's business segments — inventory usage changed year-over-year?
Castle Biosciences's business segments — inventory usage increased by 36.1% year-over-year, from $4.73M to $6.44M.
What is the long-term trend for Castle Biosciences's business segments — inventory usage?
Over 3 years (2022 to 2025), Castle Biosciences's business segments — inventory usage has grown at a 30.3% compound annual growth rate (CAGR), from $9.86M to $21.82M.
What does business segments — inventory usage mean?
Reflects the cost of materials and supplies consumed during the production or delivery of diagnostic services within the segment. This is a key indicator of direct variable costs and supply chain efficiency.